Acquired isodisomy for chromosome 13 is common in AML, and associated with FLT3-itd mutations

被引：36

作者：

Griffiths, M ^{[1
]}

Mason, J

Rindl, M

Akiki, S

McMullan, D

Stinton, V

Powell, H

Curtis, A

Bown, N

Craddock, C

机构：

[1] Birmingham Womens Hosp, W Midlands Reg Genet Lab, Birmingham B15 2TG, W Midlands, England

[2] Inst Human Genet, Reg Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England

[3] Univ Hosp Birmingham, Dept Haematol, Birmingham, W Midlands, England

来源：

LEUKEMIA | 2005年 / 19卷 / 12期

关键词：

D O I：

10.1038/sj.leu.2403988

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2355 / 2358

页数：4

共 9 条

[1] Genomic structure of human FLT3:: Implications for mutational analysis [J].

Abu-Duhier, FM ;

Goodeve, AC ;

Wilson, GA ;

Care, RS ;

Peake, IR ;

Reilly, JT .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (04) :1076-1077

[2] FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group [J].

Abu-Duhier, FM ;

Goodeve, AC ;

Wilson, GA ;

Gari, MA ;

Peake, IR ;

Rees, DC ;

Vandenberghe, EA ;

Winship, PR ;

Reilly, JT .

BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (01) :190-195

[3] The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials [J].

Kottaridis, PD ;

Gale, RE ;

Frew, ME ;

Harrison, G ;

Langabeer, SE ;

Belton, AA ;

Walker, H ;

Wheatley, K ;

Bowen, DT ;

Burnett, AK ;

Goldstone, AH ;

Linch, DC .

BLOOD, 2001, 98 (06) :1752-1759

[4] Development and implementation of a new rapid aneuploidy diagnostic service within the UK National Health Service and implications for the future of prenatal diagnosis [J].

Mann, K ;

Fox, SP ;

Abbs, SJ ;

Yau, SC ;

Scriven, PN ;

Docherty, Z ;

Ogilvie, CM .

LANCET, 2001, 358 (9287) :1057-1061

[5]

Raghavan M, 2005, CANCER RES, V65, P375

[6] Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia:: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease [J].

Schnittger, S ;

Schoch, C ;

Dugas, M ;

Kern, W ;

Staib, P ;

Wuchter, C ;

Löffler, H ;

Sauerland, CM ;

Serve, H ;

Büchner, T ;

Haferlach, T ;

Hiddemann, W .

BLOOD, 2002, 100 (01) :59-66

[7] The role of FLT3 in haematopoietic malignancies [J].

Stirewalt, DL ;

Radich, JP .

NATURE REVIEWS CANCER, 2003, 3 (09) :650-U1

[8] Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia:: association with FAB subtypes and identification of subgroups with poor prognosis [J].

Thiede, C ;

Steudel, C ;

Mohr, B ;

Schaich, M ;

Schäkel, U ;

Platzbecker, U ;

Wermke, M ;

Bornhäuser, M ;

Ritter, M ;

Neubauer, A ;

Ehninger, G ;

Illmer, T .

BLOOD, 2002, 99 (12) :4326-4335

[9]

Whitman SP, 2001, CANCER RES, V61, P7233

← 1 →